Developer docs
API playgroundTry for free, no card

Search company profiles

SCCORE AI TECH DIAGNOSTIC LIMITED

Full company profile

uuid025pkgq

Namestring
SCCORE AI TECH DIAGNOSTIC LIMITED
Legal namestring
Sccore AI Tech Diagnostic LTD
Company typeenum
Private
Founded yearint
2026
Descriptiontext

SCCORE AI TECH DIAGNOSTIC LIMITED is a privately held healthcare technology company that develops and manufactures AI-powered autonomous health screening kiosks for preventive diagnostics. The company operates a dual-hub model with indigenous hardware manufacturing in Ras Al Khaimah, UAE and a dedicated AI research and software engineering hub in Limassol, Cyprus, enabling full in-house control over both the physical terminal stack and the proprietary deep-learning models that drive screening. Its three product lines — Medigo (general adult screening, 75+ clinical parameters in 10 minutes), Kidigo (pediatric screening, 100+ assessments with AI autism and developmental screening), and Femigo (women's and maternal health screening) — are designed for deployment in schools, corporate hubs, government health programs, healthcare distributors, and remote or underserved communities.

The underlying technology combines clinical-grade certified sensors (6-lead ECG, digital spirometry, digital auscultation, vision, skin, oral, MUAC) with proprietary machine-learning models that process multimodal diagnostic data locally at the edge, eliminating reliance on third-party or white-label platforms. The platform is offline-capable with battery backup and syncs to a HIPAA-compliant cloud, enabling deployment in low-connectivity settings, and routes outputs via WhatsApp/SMS reports and secure APIs into enterprise dashboards and Hospital Management Systems.

The business model is hybrid: one-time hardware sales (CapEx) plus recurring AI analytics and telemedicine subscription (Opex), supported by direct enterprise field sales and a four-track channel partner program (Distribution, Government, Enterprise, Education). The company is certified to ISO 13485, CE Mark, USFDA, and HIPAA standards, and is led by founders Ravindra Raul (CEO) and Dr. Ankit Desai (COO) alongside a chairman and honorary chairman with global public-health credentials. No external institutional funding rounds have been disclosed.

Short descriptiontext

SCCORE AI TECH DIAGNOSTIC LIMITED develops and manufactures AI-powered autonomous health screening kiosks (Medigo, Kidigo, Femigo) that capture 75+ clinical parameters in 10 minutes, selling via CapEx and subscription to enterprises, schools, governments, and healthcare distributors globally.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI healthcare robotics, preventive health screening, autonomous diagnostic kiosks, clinical screening devices, pediatric health assessment
Industry2 codes
1Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
CodeHLAHACALPrimaryYes
2Medical Imaging AI
CodeHDAAAEAHPrimaryNo
NAICS code1 code
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
AI Healthcare Robotics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Autonomous Health Screening Kiosk Sales
TypeHardware Sales
Description

Sale of hardware platforms (Medigo, Kidigo, Femigo) to enterprise, institutional, and government clients. CapEx model with allocation and termination policies per master enterprise service agreements.

sccoreaitech.com
2AI Analytics & Telemedicine Services
TypeSubscription Recurring
Description

Ongoing AI-driven diagnostic analysis, smart health reports delivered via SMS/WhatsApp, and telemedicine consultation services. Subscription or per-use model.

sccoreaitech.com
3Healthcare Partnership & Distribution
TypeLicensing Royalties
Description

Revenue from deploying screening infrastructure through healthcare innovation partnerships, distributors, and operators in global sectors.

sccoreaitech.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details2 tiers
1Enterprise / Institutional Purchase (Capex)
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Direct purchase of autonomous screening platforms for enterprise, government, and institutional deployments. Termination policies apply per master enterprise service agreement.

sccoreaitech.com
2Rental / Operational Model (Opex)
ModelSubscriptionBilling cadenceAnnual
Notes

Rental model available for organizations preferring operational expenditure over capital investment. Includes ongoing AI analytics and cloud services.

sccoreaitech.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Medigo
Description

AI-powered health screening kiosk delivering 75+ health assessments in under 10 minutes for general population preventive healthcare.

sccoreaitech.com
+2 more records
Core offering1 text field

SCCORE AI Tech designs, manufactures, and sells AI-powered autonomous health screening kiosks and robots for preventive diagnostics. Its three core hardware products — Medigo (general adult screening, 75+ parameters in 10 minutes), Kidigo (pediatric screening, 100+ pediatric assessments with AI autism screening), and Femigo (women's health screening) — combine clinical-grade certified sensors with proprietary deep-learning AI models developed in Cyprus. The company sells and rents these platforms to enterprises, schools, government agencies, and healthcare distributors globally, complemented by ongoing AI analytics, telemedicine, and digital health report subscription services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 95% screening accuracy with clinical-grade sensors
+3 more records
Product overview1 text field

SCCORE AI Tech delivers an integrated AI Healthcare Robotics ecosystem for preventive screening through three distinct product lines: Medigo (adult health screening kiosk with 75+ tests), Kidigo (pediatric screening robot with 100+ assessments), and Femigo (women's health infrastructure). The platform combines autonomous health kiosks with proprietary AI models developed in Cyprus and hardware manufactured in the UAE, enabling continuous, population-scale preventive healthcare screening.

Product and service4 records
1Medigo
CategoryAI Healthcare Robotics - Adult Screening
Description

AI-powered autonomous health screening kiosk delivering 75+ clinical health assessments, intelligent health insights, and instant digital reports in under 10 minutes; designed for preventive healthcare screening at scale in corporate hubs, public spaces, and healthcare facilities.

2Kidigo
CategoryAI Healthcare Robotics - Pediatric Screening
Description

Child-friendly AI robotic wellness companion for schools, clinics, and early childhood institutions delivering 100+ pediatric assessments including AI autism screening, gamified interaction, built-in telemedicine, and longitudinal WHO growth chart tracking.

3Femigo
CategoryAI Healthcare Robotics - Women's Health Screening
Description

Privacy-first women's health screening layer for clinics, institutions, and maternal health programs, engineered for dignified, clinical-grade maternal health screening at scale.

4AI Analytics and Telemedicine Services
CategoryAI Analytics and Telemedicine Services
Description

Ongoing AI-driven diagnostic analysis, smart health reports delivered via SMS/WhatsApp, and telemedicine consultation services provided on a subscription or per-use basis alongside the company's screening kiosk deployments.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Healthcare Innovation Partnership Ecosystem
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Full zero-dependency screening infrastructure partnerships providing 75+ certified clinical parameters, robust offline edge computing, and heavy-duty battery backups for uninterrupted operational reliability anywhere in the world. Integration with existing corporate environments, school networks, and public health systems.

sccoreaitech.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Ada Health provides an AI symptom assessment and care navigation platform used by health systems, insurers, and employers. Comparable AI health assessment positioning and enterprise/government GTM, but app-first rather than hardware-screening model.

TypeDirect peer
Description

Withings produces connected health devices (BPM Core, Body Scan, ScanWatch) for vitals, ECG, and body composition screening with companion apps and health platforms. Comparable connected health screening device portfolio targeting consumer and enterprise wellness.

TypeDirect peer
Description

Forward (formerly Forward Health) operates AI-powered preventive care clinics and health kiosks (CarePods) for continuous biometric monitoring and screening. Most direct competitor to Sccore AI Tech's autonomous health screening kiosks targeting enterprise and consumer preventive care.

TypeDirect peer
Description

AliveCor (KardiaMobile) makes AI-driven ECG/ECG screening devices that deliver clinical-grade cardiac diagnostics for consumers and enterprises. Comparable AI cardiac screening (6-lead ECG) capability as Sccore's Medigo platform.

TypeBroad incumbent
Description

Tempus applies AI to clinical and molecular data for diagnostics and precision medicine, serving health systems, life sciences, and patients. Broad AI-diagnostics incumbent with overlapping enterprise healthcare buyer base, though focused on data-driven rather than physical screening.

TypeBroad incumbent
Description

Babylon Health (now eMed) provides AI-driven health assessment, virtual care, and population health platforms to enterprises and governments globally. Broad incumbent in AI healthcare with overlapping enterprise/government distribution motion but different delivery (virtual-first vs. hardware kiosks).

TypeDirect peer
Description

Eko Health builds AI-powered digital stethoscopes and cardiac screening devices with FDA-cleared algorithms for heart and lung auscultation. Directly overlaps with Sccore's digital auscultation, ECG, and pulmonary function screening features.

TypeDirect peer
Description

TytoCare provides connected remote diagnostic devices that enable comprehensive telehealth examinations including heart, lung, skin, and throat from any location. Directly comparable to Sccore's remote autonomous screening model with AI-assisted diagnostics and edge capture.

TypeDirect peer
Description

Butterfly Network manufactures AI-powered handheld ultrasound devices with cloud and edge processing for point-of-care imaging across clinical and remote settings. Comparable AI-enabled portable diagnostic hardware with edge inference for medical imaging.

TypeEmerging player
Description

Biofourmis delivers AI-based remote patient monitoring and predictive analytics for hospitals and pharmaceutical clients. Comparable AI-driven continuous health monitoring model, though primarily software/cloud rather than physical screening kiosks.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SCCORE AI TECH DIAGNOSTIC LIMITED

AI Healthcare Roboticssccoreaitech.com

SCCORE AI TECH DIAGNOSTIC LIMITED develops and manufactures AI-powered autonomous health screening kiosks (Medigo, Kidigo, Femigo) that capture 75+ clinical parameters in 10 minutes, selling via CapEx and subscription to enterprises, schools, governments, and healthcare distributors globally.

What SCCORE AI TECH DIAGNOSTIC LIMITED does

SCCORE AI TECH DIAGNOSTIC LIMITED is a privately held healthcare technology company that develops and manufactures AI-powered autonomous health screening kiosks for preventive diagnostics. The company operates a dual-hub model with indigenous hardware manufacturing in Ras Al Khaimah, UAE and a dedicated AI research and software engineering hub in Limassol, Cyprus, enabling full in-house control over both the physical terminal stack and the proprietary deep-learning models that drive screening. Its three product lines — Medigo (general adult screening, 75+ clinical parameters in 10 minutes), Kidigo (pediatric screening, 100+ assessments with AI autism and developmental screening), and Femigo (women's and maternal health screening) — are designed for deployment in schools, corporate hubs, government health programs, healthcare distributors, and remote or underserved communities.

The underlying technology combines clinical-grade certified sensors (6-lead ECG, digital spirometry, digital auscultation, vision, skin, oral, MUAC) with proprietary machine-learning models that process multimodal diagnostic data locally at the edge, eliminating reliance on third-party or white-label platforms. The platform is offline-capable with battery backup and syncs to a HIPAA-compliant cloud, enabling deployment in low-connectivity settings, and routes outputs via WhatsApp/SMS reports and secure APIs into enterprise dashboards and Hospital Management Systems.

The business model is hybrid: one-time hardware sales (CapEx) plus recurring AI analytics and telemedicine subscription (Opex), supported by direct enterprise field sales and a four-track channel partner program (Distribution, Government, Enterprise, Education). The company is certified to ISO 13485, CE Mark, USFDA, and HIPAA standards, and is led by founders Ravindra Raul (CEO) and Dr. Ankit Desai (COO) alongside a chairman and honorary chairman with global public-health credentials. No external institutional funding rounds have been disclosed.

SCCORE AI TECH DIAGNOSTIC LIMITED firmographics

Firmographics
Name
SCCORE AI TECH DIAGNOSTIC LIMITED
Legal name
Sccore AI Tech Diagnostic LTD
Website
https://sccoreaitech.com
Company type
Private
Founded year
2026
Operating status
Operating
Short description
SCCORE AI TECH DIAGNOSTIC LIMITED develops and manufactures AI-powered autonomous health screening kiosks (Medigo, Kidigo, Femigo) that capture 75+ clinical parameters in 10 minutes, selling via CapEx and subscription to enterprises, schools, governments, and healthcare distributors globally.
Ownership category
akta.pro rank

SCCORE AI TECH DIAGNOSTIC LIMITED industry classification

Industry
Product category
AI Healthcare Robotics
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)
akta.pro secondary industry
Medical Imaging AI (HDAAAEAH)

Keywords

  • AI healthcare robotics
  • Preventive health screening
  • Autonomous diagnostic kiosks
  • Clinical screening devices
  • Pediatric health assessment

SCCORE AI TECH DIAGNOSTIC LIMITED business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Autonomous Health Screening Kiosk Sales: Sale of hardware platforms (Medigo, Kidigo, Femigo) to enterprise, institutional, and government clients. CapEx model with allocation and termination policies per master enterprise service agreements.
  2. AI Analytics & Telemedicine Services: Ongoing AI-driven diagnostic analysis, smart health reports delivered via SMS/WhatsApp, and telemedicine consultation services. Subscription or per-use model.
  3. Healthcare Partnership & Distribution: Revenue from deploying screening infrastructure through healthcare innovation partnerships, distributors, and operators in global sectors.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractEnterprise / Institutional Purchase (Capex)
SubscriptionAnnualRental / Operational Model (Opex)

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

SCCORE AI TECH DIAGNOSTIC LIMITED product offering

Product offering

Core offering

SCCORE AI Tech designs, manufactures, and sells AI-powered autonomous health screening kiosks and robots for preventive diagnostics. Its three core hardware products — Medigo (general adult screening, 75+ parameters in 10 minutes), Kidigo (pediatric screening, 100+ pediatric assessments with AI autism screening), and Femigo (women's health screening) — combine clinical-grade certified sensors with proprietary deep-learning AI models developed in Cyprus. The company sells and rents these platforms to enterprises, schools, government agencies, and healthcare distributors globally, complemented by ongoing AI analytics, telemedicine, and digital health report subscription services.

Product overview

SCCORE AI Tech delivers an integrated AI Healthcare Robotics ecosystem for preventive screening through three distinct product lines: Medigo (adult health screening kiosk with 75+ tests), Kidigo (pediatric screening robot with 100+ assessments), and Femigo (women's health infrastructure). The platform combines autonomous health kiosks with proprietary AI models developed in Cyprus and hardware manufactured in the UAE, enabling continuous, population-scale preventive healthcare screening.

Differentiator

Problem solved

Functional benefit

Brands

  • Medigo: AI-powered health screening kiosk delivering 75+ health assessments in under 10 minutes for general population preventive healthcare.
  • Kidigo
  • Femigo

Products and services

  • Medigo AI-powered autonomous health screening kiosk delivering 75+ clinical health assessments, intelligent health insights, and instant digital reports in under 10 minutes; designed for preventive healthcare screening at scale in corporate hubs, public spaces, and healthcare facilities.
  • Kidigo Child-friendly AI robotic wellness companion for schools, clinics, and early childhood institutions delivering 100+ pediatric assessments including AI autism screening, gamified interaction, built-in telemedicine, and longitudinal WHO growth chart tracking.
  • Femigo Privacy-first women's health screening layer for clinics, institutions, and maternal health programs, engineered for dignified, clinical-grade maternal health screening at scale.
  • AI Analytics and Telemedicine Services Ongoing AI-driven diagnostic analysis, smart health reports delivered via SMS/WhatsApp, and telemedicine consultation services provided on a subscription or per-use basis alongside the company's screening kiosk deployments.

Quantifiable outcome

  • 95% screening accuracy with clinical-grade sensors
  • +3 more outcomes

Companies that use SCCORE AI TECH DIAGNOSTIC LIMITED

Customer profile

Segments6 records

Ideal customer profiles5 records

SCCORE AI TECH DIAGNOSTIC LIMITED technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability8 records

Feature7 records

SCCORE AI TECH DIAGNOSTIC LIMITED partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Healthcare Innovation Partnership EcosystemcoreStrategic or Co-development PartnerFull zero-dependency screening infrastructure partnerships providing 75+ certified clinical parameters, robust offline edge computing, and heavy-duty battery backups for uninterrupted operational reliability anywhere in the world. Integration with existing corporate environments, school networks, and public health systems.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

SCCORE AI TECH DIAGNOSTIC LIMITED competitors and assessment

Company assessment

Emerging players

  • Ada Health: Ada Health provides an AI symptom assessment and care navigation platform used by health systems, insurers, and employers. Comparable AI health assessment positioning and enterprise/government GTM, but app-first rather than hardware-screening model.
  • Biofourmis: Biofourmis delivers AI-based remote patient monitoring and predictive analytics for hospitals and pharmaceutical clients. Comparable AI-driven continuous health monitoring model, though primarily software/cloud rather than physical screening kiosks.

Direct peers

  • Withings: Withings produces connected health devices (BPM Core, Body Scan, ScanWatch) for vitals, ECG, and body composition screening with companion apps and health platforms. Comparable connected health screening device portfolio targeting consumer and enterprise wellness.
  • Forward Health: Forward (formerly Forward Health) operates AI-powered preventive care clinics and health kiosks (CarePods) for continuous biometric monitoring and screening. Most direct competitor to Sccore AI Tech's autonomous health screening kiosks targeting enterprise and consumer preventive care.
  • AliveCor: AliveCor (KardiaMobile) makes AI-driven ECG/ECG screening devices that deliver clinical-grade cardiac diagnostics for consumers and enterprises. Comparable AI cardiac screening (6-lead ECG) capability as Sccore's Medigo platform.
  • Eko Health: Eko Health builds AI-powered digital stethoscopes and cardiac screening devices with FDA-cleared algorithms for heart and lung auscultation. Directly overlaps with Sccore's digital auscultation, ECG, and pulmonary function screening features.
  • TytoCare: TytoCare provides connected remote diagnostic devices that enable comprehensive telehealth examinations including heart, lung, skin, and throat from any location. Directly comparable to Sccore's remote autonomous screening model with AI-assisted diagnostics and edge capture.
  • Butterfly Network: Butterfly Network manufactures AI-powered handheld ultrasound devices with cloud and edge processing for point-of-care imaging across clinical and remote settings. Comparable AI-enabled portable diagnostic hardware with edge inference for medical imaging.

Broad incumbents

  • Tempus: Tempus applies AI to clinical and molecular data for diagnostics and precision medicine, serving health systems, life sciences, and patients. Broad AI-diagnostics incumbent with overlapping enterprise healthcare buyer base, though focused on data-driven rather than physical screening.
  • Babylon Health: Babylon Health (now eMed) provides AI-driven health assessment, virtual care, and population health platforms to enterprises and governments globally. Broad incumbent in AI healthcare with overlapping enterprise/government distribution motion but different delivery (virtual-first vs. hardware kiosks).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

SCCORE AI TECH DIAGNOSTIC LIMITED social profiles

Digital presence

SCCORE AI TECH DIAGNOSTIC LIMITED compliance and trust

Trust signal

Compliance4 records

SCCORE AI TECH DIAGNOSTIC LIMITED financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SCCORE AI TECH DIAGNOSTIC LIMITED leadership team

Management profile

Number of profiles

Profiles9 records

SCCORE AI TECH DIAGNOSTIC LIMITED funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SCCORE AI TECH DIAGNOSTIC LIMITED M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SCCORE AI TECH DIAGNOSTIC LIMITED

What does SCCORE AI TECH DIAGNOSTIC LIMITED do?

SCCORE AI Tech designs, manufactures, and sells AI-powered autonomous health screening kiosks and robots for preventive diagnostics. Its three core hardware products — Medigo (general adult screening, 75+ parameters in 10 minutes), Kidigo (pediatric screening, 100+ pediatric assessments with AI autism screening), and Femigo (women's health screening) — combine clinical-grade certified sensors with proprietary deep-learning AI models developed in Cyprus. The company sells and rents these platforms to enterprises, schools, government agencies, and healthcare distributors globally, complemented by ongoing AI analytics, telemedicine, and digital health report subscription services.

Is SCCORE AI TECH DIAGNOSTIC LIMITED a public or private company?

SCCORE AI TECH DIAGNOSTIC LIMITED is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was SCCORE AI TECH DIAGNOSTIC LIMITED founded?

SCCORE AI TECH DIAGNOSTIC LIMITED was founded in 2026.

How does SCCORE AI TECH DIAGNOSTIC LIMITED make money?

Three revenue lines are on record. Autonomous Health Screening Kiosk Sales are the primary driver. The others are AI Analytics & Telemedicine Services and healthcare Partnership & Distribution.

Who are SCCORE AI TECH DIAGNOSTIC LIMITED's main competitors?

Emerging players on record are Ada Health and Biofourmis. Direct peers are Withings, Forward Health, AliveCor, Eko Health, TytoCare and Butterfly Network. Broad incumbents are Tempus and Babylon Health.

Does SCCORE AI TECH DIAGNOSTIC LIMITED have an API?

No public API is recorded for SCCORE AI TECH DIAGNOSTIC LIMITED.

What industry is SCCORE AI TECH DIAGNOSTIC LIMITED in?

SCCORE AI TECH DIAGNOSTIC LIMITED's product category is AI Healthcare Robotics. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 33451 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals